<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ja">
	<id>https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E</id>
	<title>脳神経内科領域用語 - 版の履歴</title>
	<link rel="self" type="application/atom+xml" href="https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E"/>
	<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E&amp;action=history"/>
	<updated>2026-09-06T02:24:16Z</updated>
	<subtitle>このウィキのこのページに関する変更履歴</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E&amp;diff=52351&amp;oldid=prev</id>
		<title>WikiSysop: /* 追加候補用語 */</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E&amp;diff=52351&amp;oldid=prev"/>
		<updated>2026-09-05T22:28:50Z</updated>

		<summary type="html">&lt;p&gt;&lt;span class=&quot;autocomment&quot;&gt;追加候補用語&lt;/span&gt;&lt;/p&gt;
&lt;a href=&quot;https://bsd.neuroinf.jp/w/index.php?title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E&amp;amp;diff=52351&amp;amp;oldid=52350&quot;&gt;差分を表示&lt;/a&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E&amp;diff=52350&amp;oldid=prev</id>
		<title>2026年9月5日 (土) 22:28にWikiSysopによる</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E&amp;diff=52350&amp;oldid=prev"/>
		<updated>2026-09-05T22:28:08Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://bsd.neuroinf.jp/w/index.php?title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E&amp;amp;diff=52350&amp;amp;oldid=52348&quot;&gt;差分を表示&lt;/a&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E&amp;diff=52348&amp;oldid=prev</id>
		<title>WikiSysop: ページの作成:「==完成した用語== {| class=&quot;wikitable&quot; |+ 神経変性疾患に関連する既存項目 ! 分類 ! 項目名 ! 同義語・略語・英語名 |- ! rowspan=&quot;13&quot; | 疾患・疾患群 | アルツハイマー病 | Alzheimer病、Alzheimer&#039;s disease、Alzheimer disease、AD |- | レビー小体型認知症 | dementia with Lewy bodies、DLB、Lewy body dementia |- | 多系統萎縮症 | multiple system atrophy、MSA |- | 進行性核上性麻痺 | pro…」</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=%E8%84%B3%E7%A5%9E%E7%B5%8C%E5%86%85%E7%A7%91%E9%A0%98%E5%9F%9F%E7%94%A8%E8%AA%9E&amp;diff=52348&amp;oldid=prev"/>
		<updated>2026-09-05T00:07:48Z</updated>

		<summary type="html">&lt;p&gt;ページの作成:「==完成した用語== {| class=&amp;quot;wikitable&amp;quot; |+ 神経変性疾患に関連する既存項目 ! 分類 ! 項目名 ! 同義語・略語・英語名 |- ! rowspan=&amp;quot;13&amp;quot; | 疾患・疾患群 | &lt;a href=&quot;/wiki/%E3%82%A2%E3%83%AB%E3%83%84%E3%83%8F%E3%82%A4%E3%83%9E%E3%83%BC%E7%97%85&quot; title=&quot;アルツハイマー病&quot;&gt;アルツハイマー病&lt;/a&gt; | Alzheimer病、Alzheimer&amp;#039;s disease、Alzheimer disease、AD |- | &lt;a href=&quot;/wiki/%E3%83%AC%E3%83%93%E3%83%BC%E5%B0%8F%E4%BD%93%E5%9E%8B%E8%AA%8D%E7%9F%A5%E7%97%87&quot; title=&quot;レビー小体型認知症&quot;&gt;レビー小体型認知症&lt;/a&gt; | dementia with Lewy bodies、DLB、Lewy body dementia |- | &lt;a href=&quot;/wiki/%E5%A4%9A%E7%B3%BB%E7%B5%B1%E8%90%8E%E7%B8%AE%E7%97%87&quot; title=&quot;多系統萎縮症&quot;&gt;多系統萎縮症&lt;/a&gt; | multiple system atrophy、MSA |- | &lt;a href=&quot;/wiki/%E9%80%B2%E8%A1%8C%E6%80%A7%E6%A0%B8%E4%B8%8A%E6%80%A7%E9%BA%BB%E7%97%BA&quot; title=&quot;進行性核上性麻痺&quot;&gt;進行性核上性麻痺&lt;/a&gt; | pro…」&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新規ページ&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==完成した用語==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+ 神経変性疾患に関連する既存項目&lt;br /&gt;
! 分類&lt;br /&gt;
! 項目名&lt;br /&gt;
! 同義語・略語・英語名&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;13&amp;quot; | 疾患・疾患群&lt;br /&gt;
| [[アルツハイマー病]]&lt;br /&gt;
| Alzheimer病、Alzheimer&amp;#039;s disease、Alzheimer disease、AD&lt;br /&gt;
|-&lt;br /&gt;
| [[レビー小体型認知症]]&lt;br /&gt;
| dementia with Lewy bodies、DLB、Lewy body dementia&lt;br /&gt;
|-&lt;br /&gt;
| [[多系統萎縮症]]&lt;br /&gt;
| multiple system atrophy、MSA&lt;br /&gt;
|-&lt;br /&gt;
| [[進行性核上性麻痺]]&lt;br /&gt;
| progressive supranuclear palsy、PSP、Steele-Richardson-Olszewski syndrome&lt;br /&gt;
|-&lt;br /&gt;
| [[筋萎縮性側索硬化症]]&lt;br /&gt;
| amyotrophic lateral sclerosis、ALS&lt;br /&gt;
|-&lt;br /&gt;
| [[脊髄性筋萎縮症]]&lt;br /&gt;
| spinal muscular atrophy、SMA&lt;br /&gt;
|-&lt;br /&gt;
| [[ハンチントン病]]&lt;br /&gt;
| Huntington disease、Huntington&amp;#039;s disease、HD&lt;br /&gt;
|-&lt;br /&gt;
| [[脊髄小脳変性症]]&lt;br /&gt;
| spinocerebellar degeneration、SCD&lt;br /&gt;
|-&lt;br /&gt;
| [[前頭側頭型認知症]]&lt;br /&gt;
| frontotemporal dementia、FTD&lt;br /&gt;
|-&lt;br /&gt;
| [[意味性認知症]]&lt;br /&gt;
| semantic dementia、SD&lt;br /&gt;
|-&lt;br /&gt;
| [[シャルコー・マリー・トゥース病]]&lt;br /&gt;
| Charcot-Marie-Tooth disease、CMT、hereditary motor and sensory neuropathy、HMSN&lt;br /&gt;
|-&lt;br /&gt;
| [[筋強直性ジストロフィー]]&lt;br /&gt;
| myotonic dystrophy、DM、dystrophia myotonica&lt;br /&gt;
|-&lt;br /&gt;
| [[プリオン]]&lt;br /&gt;
| prion&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;5&amp;quot; | アルツハイマー病・アミロイド・タウ関連&lt;br /&gt;
| [[アミロイドβタンパク質]]&lt;br /&gt;
| amyloid-β protein、amyloid beta、Aβ、amyloid-β peptide、アミロイドβペプチド&lt;br /&gt;
|-&lt;br /&gt;
| [[タウ]]&lt;br /&gt;
| tau、tau protein、タウタンパク質、MAPT&lt;br /&gt;
|-&lt;br /&gt;
| [[ニカストリン]]&lt;br /&gt;
| nicastrin、NCSTN&lt;br /&gt;
|-&lt;br /&gt;
| [[ネプリライシン]]&lt;br /&gt;
| neprilysin、neutral endopeptidase、NEP、MME&lt;br /&gt;
|-&lt;br /&gt;
| [[アミロイドーシス]]&lt;br /&gt;
| amyloidosis&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;6&amp;quot; | タンパク質分解・細胞内品質管理&lt;br /&gt;
| [[ユビキチン]]&lt;br /&gt;
| ubiquitin、Ub&lt;br /&gt;
|-&lt;br /&gt;
| [[ユビキチンリガーゼ]]&lt;br /&gt;
| ubiquitin ligase、E3 ubiquitin ligase、E3&lt;br /&gt;
|-&lt;br /&gt;
| [[プロテアソーム]]&lt;br /&gt;
| proteasome、26S proteasome&lt;br /&gt;
|-&lt;br /&gt;
| [[オートファジー]]&lt;br /&gt;
| autophagy、macroautophagy&lt;br /&gt;
|-&lt;br /&gt;
| [[リソソーム]]&lt;br /&gt;
| lysosome&lt;br /&gt;
|-&lt;br /&gt;
| [[小胞体ストレス]]&lt;br /&gt;
| endoplasmic reticulum stress、ER stress&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;6&amp;quot; | ALS・FTLD関連&lt;br /&gt;
| [[TAR DNA-binding protein of 43 kDa]]&lt;br /&gt;
| TDP-43、TAR DNA-binding protein 43、TARDBP&lt;br /&gt;
|-&lt;br /&gt;
| [[Fused in sarcoma]]&lt;br /&gt;
| FUS、TLS、translocated in liposarcoma&lt;br /&gt;
|-&lt;br /&gt;
| [[銅・亜鉛-スーパーオキシドディスムターゼ]]&lt;br /&gt;
| Cu/Zn-superoxide dismutase、Cu/Zn-SOD、SOD1&lt;br /&gt;
|-&lt;br /&gt;
| [[Chromosome 9 open reading frame 72]]&lt;br /&gt;
| C9orf72、C9ORF72&lt;br /&gt;
|-&lt;br /&gt;
| [[液-液相分離]]&lt;br /&gt;
| liquid-liquid phase separation、LLPS、phase separation、液液相分離&lt;br /&gt;
|-&lt;br /&gt;
| [[RNA結合タンパク質]]&lt;br /&gt;
| RNA-binding protein、RBP&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;4&amp;quot; | パーキンソン病関連&lt;br /&gt;
| [[αシヌクレイン]]&lt;br /&gt;
| alpha-synuclein、α-synuclein、SNCA&lt;br /&gt;
|-&lt;br /&gt;
| [[Parkin]]&lt;br /&gt;
| parkin、PRKN、PARK2&lt;br /&gt;
|-&lt;br /&gt;
| [[ミトコンドリア]]&lt;br /&gt;
| mitochondrion、mitochondria&lt;br /&gt;
|-&lt;br /&gt;
| [[エンドソーム]]&lt;br /&gt;
| endosome&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;6&amp;quot; | 神経炎症・グリア&lt;br /&gt;
| [[ミクログリア]]&lt;br /&gt;
| microglia、microglial cell&lt;br /&gt;
|-&lt;br /&gt;
| [[インフラマソーム]]&lt;br /&gt;
| inflammasome&lt;br /&gt;
|-&lt;br /&gt;
| [[アストロサイト]]&lt;br /&gt;
| astrocyte、astroglia&lt;br /&gt;
|-&lt;br /&gt;
| [[グリア細胞]]&lt;br /&gt;
| glial cell、glia、neuroglia&lt;br /&gt;
|-&lt;br /&gt;
| [[サイトカイン]]&lt;br /&gt;
| cytokine&lt;br /&gt;
|-&lt;br /&gt;
| [[ケモカイン]]&lt;br /&gt;
| chemokine&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;8&amp;quot; | 細胞骨格・軸索&lt;br /&gt;
| [[中間径フィラメント]]&lt;br /&gt;
| intermediate filament、intermediate filaments&lt;br /&gt;
|-&lt;br /&gt;
| [[ニューロフィラメント]]&lt;br /&gt;
| neurofilament、NF&lt;br /&gt;
|-&lt;br /&gt;
| [[微小管]]&lt;br /&gt;
| microtubule&lt;br /&gt;
|-&lt;br /&gt;
| [[チュブリン]]&lt;br /&gt;
| tubulin&lt;br /&gt;
|-&lt;br /&gt;
| [[アクチン]]&lt;br /&gt;
| actin&lt;br /&gt;
|-&lt;br /&gt;
| [[軸索輸送]]&lt;br /&gt;
| axonal transport、axoplasmic transport&lt;br /&gt;
|-&lt;br /&gt;
| [[ダイニン]]&lt;br /&gt;
| dynein&lt;br /&gt;
|-&lt;br /&gt;
| [[キネシン]]&lt;br /&gt;
| kinesin&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;6&amp;quot; | 細胞死・ストレス&lt;br /&gt;
| [[アポトーシス]]&lt;br /&gt;
| apoptosis、programmed cell death&lt;br /&gt;
|-&lt;br /&gt;
| [[ネクローシス]]&lt;br /&gt;
| necrosis&lt;br /&gt;
|-&lt;br /&gt;
| [[酸化ストレス]]&lt;br /&gt;
| oxidative stress&lt;br /&gt;
|-&lt;br /&gt;
| [[興奮毒性]]&lt;br /&gt;
| excitotoxicity&lt;br /&gt;
|-&lt;br /&gt;
| [[カルパイン]]&lt;br /&gt;
| calpain&lt;br /&gt;
|-&lt;br /&gt;
| [[カスパーゼ]]&lt;br /&gt;
| caspase&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;5&amp;quot; | 遺伝・分子機構&lt;br /&gt;
| [[トリプレットリピート病]]&lt;br /&gt;
| trinucleotide repeat disorder、trinucleotide repeat disease、triplet repeat disease&lt;br /&gt;
|-&lt;br /&gt;
| [[ポリグルタミン]]&lt;br /&gt;
| polyglutamine、polyQ&lt;br /&gt;
|-&lt;br /&gt;
| [[選択的スプライシング]]&lt;br /&gt;
| alternative splicing&lt;br /&gt;
|-&lt;br /&gt;
| [[伝令RNA]]&lt;br /&gt;
| messenger RNA、mRNA&lt;br /&gt;
|-&lt;br /&gt;
| [[14-3-3タンパク質]]&lt;br /&gt;
| 14-3-3 protein、14-3-3 proteins&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==追加候補用語==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+ 神経変性疾患に関連する新規項目候補&lt;br /&gt;
! 分類&lt;br /&gt;
! 新規項目候補&lt;br /&gt;
! 同義語・略語・英語名&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;15&amp;quot; | 疾患・疾患群&lt;br /&gt;
| [[神経変性疾患]]&lt;br /&gt;
| neurodegenerative disease、neurodegenerative disorders&lt;br /&gt;
|-&lt;br /&gt;
| [[パーキンソン病]]&lt;br /&gt;
| Parkinson病、Parkinson disease、Parkinson&amp;#039;s disease、PD&lt;br /&gt;
|-&lt;br /&gt;
| [[パーキンソニズム]]&lt;br /&gt;
| parkinsonism、パーキンソン症候&lt;br /&gt;
|-&lt;br /&gt;
| [[パーキンソン症候群]]&lt;br /&gt;
| Parkinsonian syndrome&lt;br /&gt;
|-&lt;br /&gt;
| [[前頭側頭葉変性症]]&lt;br /&gt;
| frontotemporal lobar degeneration、FTLD&lt;br /&gt;
|-&lt;br /&gt;
| [[大脳皮質基底核変性症]]&lt;br /&gt;
| corticobasal degeneration、CBD&lt;br /&gt;
|-&lt;br /&gt;
| [[大脳皮質基底核症候群]]&lt;br /&gt;
| corticobasal syndrome、CBS&lt;br /&gt;
|-&lt;br /&gt;
| [[プリオン病]]&lt;br /&gt;
| prion disease、prion diseases&lt;br /&gt;
|-&lt;br /&gt;
| [[運動ニューロン病]]&lt;br /&gt;
| motor neuron disease、motor neuron diseases、MND&lt;br /&gt;
|-&lt;br /&gt;
| [[球脊髄性筋萎縮症]]&lt;br /&gt;
| spinal and bulbar muscular atrophy、SBMA、Kennedy病、Kennedy disease&lt;br /&gt;
|-&lt;br /&gt;
| [[遺伝性痙性対麻痺]]&lt;br /&gt;
| hereditary spastic paraplegia、hereditary spastic paraparesis、HSP&lt;br /&gt;
|-&lt;br /&gt;
| [[神経核内封入体病]]&lt;br /&gt;
| neuronal intranuclear inclusion disease、NIID、neuronal intranuclear inclusion body disease&lt;br /&gt;
|-&lt;br /&gt;
| [[辺縁系優位型加齢性TDP-43脳症]]&lt;br /&gt;
| limbic-predominant age-related TDP-43 encephalopathy、LATE&lt;br /&gt;
|-&lt;br /&gt;
| [[原発性加齢関連タウオパチー]]&lt;br /&gt;
| primary age-related tauopathy、PART&lt;br /&gt;
|-&lt;br /&gt;
| [[慢性外傷性脳症]]&lt;br /&gt;
| chronic traumatic encephalopathy、CTE&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;11&amp;quot; | アルツハイマー病関連分子&lt;br /&gt;
| [[アポリポタンパク質E]]&lt;br /&gt;
| apolipoprotein E、ApoE、APOE&lt;br /&gt;
|-&lt;br /&gt;
| [[アミロイド前駆体タンパク質]]&lt;br /&gt;
| amyloid precursor protein、amyloid-β precursor protein、APP、アミロイド前駆タンパク質&lt;br /&gt;
|-&lt;br /&gt;
| [[TREM2]]&lt;br /&gt;
| triggering receptor expressed on myeloid cells 2、triggering receptor expressed on myeloid cells-2&lt;br /&gt;
|-&lt;br /&gt;
| [[プレセニリン1]]&lt;br /&gt;
| presenilin 1、presenilin-1、PSEN1、PS1&lt;br /&gt;
|-&lt;br /&gt;
| [[プレセニリン2]]&lt;br /&gt;
| presenilin 2、presenilin-2、PSEN2、PS2&lt;br /&gt;
|-&lt;br /&gt;
| [[BACE1]]&lt;br /&gt;
| beta-site APP-cleaving enzyme 1、β-site APP-cleaving enzyme 1、beta-secretase 1、β-secretase 1、βセクレターゼ1&lt;br /&gt;
|-&lt;br /&gt;
| [[γセクレターゼ]]&lt;br /&gt;
| gamma-secretase、γ-secretase&lt;br /&gt;
|-&lt;br /&gt;
| [[CD33]]&lt;br /&gt;
| CD33 molecule、Siglec-3、SIGLEC3&lt;br /&gt;
|-&lt;br /&gt;
| [[クラステリン]]&lt;br /&gt;
| clusterin、CLU、apolipoprotein J、ApoJ&lt;br /&gt;
|-&lt;br /&gt;
| [[PICALM]]&lt;br /&gt;
| phosphatidylinositol-binding clathrin assembly protein&lt;br /&gt;
|-&lt;br /&gt;
| [[BIN1]]&lt;br /&gt;
| bridging integrator 1&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;8&amp;quot; | パーキンソン病・シヌクレイノパチー関連&lt;br /&gt;
| [[PINK1]]&lt;br /&gt;
| PTEN-induced kinase 1、PTEN-induced putative kinase 1、PARK6&lt;br /&gt;
|-&lt;br /&gt;
| [[LRRK2]]&lt;br /&gt;
| leucine-rich repeat kinase 2、PARK8、dardarin&lt;br /&gt;
|-&lt;br /&gt;
| [[GBA1]]&lt;br /&gt;
| glucosylceramidase beta 1、glucocerebrosidase、β-glucocerebrosidase、GBA&lt;br /&gt;
|-&lt;br /&gt;
| [[DJ-1]]&lt;br /&gt;
| PARK7、Parkinson disease protein 7&lt;br /&gt;
|-&lt;br /&gt;
| [[VPS35]]&lt;br /&gt;
| vacuolar protein sorting 35、vacuolar protein sorting-associated protein 35&lt;br /&gt;
|-&lt;br /&gt;
| [[レビー小体]]&lt;br /&gt;
| Lewy body、Lewy bodies&lt;br /&gt;
|-&lt;br /&gt;
| [[シヌクレイノパチー]]&lt;br /&gt;
| synucleinopathy、synucleinopathies&lt;br /&gt;
|-&lt;br /&gt;
| [[マイトファジー]]&lt;br /&gt;
| mitophagy、mitochondrial autophagy&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;12&amp;quot; | ALS・FTLD関連分子&lt;br /&gt;
| [[プログラニュリン]]&lt;br /&gt;
| progranulin、GRN、PGRN&lt;br /&gt;
|-&lt;br /&gt;
| [[TMEM106B]]&lt;br /&gt;
| transmembrane protein 106B&lt;br /&gt;
|-&lt;br /&gt;
| [[TBK1]]&lt;br /&gt;
| TANK-binding kinase 1&lt;br /&gt;
|-&lt;br /&gt;
| [[オプチニューリン]]&lt;br /&gt;
| optineurin、OPTN&lt;br /&gt;
|-&lt;br /&gt;
| [[セクエストソーム1]]&lt;br /&gt;
| sequestosome 1、SQSTM1、p62&lt;br /&gt;
|-&lt;br /&gt;
| [[ユビキリン2]]&lt;br /&gt;
| ubiquilin 2、UBQLN2&lt;br /&gt;
|-&lt;br /&gt;
| [[VCP]]&lt;br /&gt;
| valosin-containing protein、p97&lt;br /&gt;
|-&lt;br /&gt;
| [[アタキシン2]]&lt;br /&gt;
| ataxin-2、ATXN2&lt;br /&gt;
|-&lt;br /&gt;
| [[hnRNPA1]]&lt;br /&gt;
| heterogeneous nuclear ribonucleoprotein A1、HNRNPA1&lt;br /&gt;
|-&lt;br /&gt;
| [[マトリン3]]&lt;br /&gt;
| matrin 3、MATR3&lt;br /&gt;
|-&lt;br /&gt;
| [[プロフィリン1]]&lt;br /&gt;
| profilin 1、PFN1&lt;br /&gt;
|-&lt;br /&gt;
| [[CHCHD10]]&lt;br /&gt;
| coiled-coil-helix-coiled-coil-helix domain-containing protein 10&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;9&amp;quot; | ポリグルタミン病・リピート伸長病・SMA関連&lt;br /&gt;
| [[ハンチンチン]]&lt;br /&gt;
| huntingtin、HTT、huntingtin protein&lt;br /&gt;
|-&lt;br /&gt;
| [[ポリグルタミン病]]&lt;br /&gt;
| polyglutamine disease、polyglutamine diseases、polyQ disease、polyQ diseases&lt;br /&gt;
|-&lt;br /&gt;
| [[リピート伸長病]]&lt;br /&gt;
| repeat expansion disease、repeat expansion disorders&lt;br /&gt;
|-&lt;br /&gt;
| [[RAN翻訳]]&lt;br /&gt;
| repeat-associated non-AUG translation、RAN translation&lt;br /&gt;
|-&lt;br /&gt;
| [[ジペプチドリピートタンパク質]]&lt;br /&gt;
| dipeptide repeat protein、DPR protein、DPR&lt;br /&gt;
|-&lt;br /&gt;
| [[アタキシン1]]&lt;br /&gt;
| ataxin-1、ATXN1&lt;br /&gt;
|-&lt;br /&gt;
| [[アタキシン3]]&lt;br /&gt;
| ataxin-3、ATXN3&lt;br /&gt;
|-&lt;br /&gt;
| [[SMN1]]&lt;br /&gt;
| survival motor neuron 1&lt;br /&gt;
|-&lt;br /&gt;
| [[SMN2]]&lt;br /&gt;
| survival motor neuron 2&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;15&amp;quot; | 神経変性疾患に共通する病理・病態&lt;br /&gt;
| [[タウオパチー]]&lt;br /&gt;
| tauopathy、tauopathies&lt;br /&gt;
|-&lt;br /&gt;
| [[TDP-43プロテイノパチー]]&lt;br /&gt;
| TDP-43 proteinopathy、TDP-43 proteinopathies&lt;br /&gt;
|-&lt;br /&gt;
| [[プロテイノパチー]]&lt;br /&gt;
| proteinopathy、proteinopathies&lt;br /&gt;
|-&lt;br /&gt;
| [[タンパク質凝集]]&lt;br /&gt;
| protein aggregation、protein aggregate formation&lt;br /&gt;
|-&lt;br /&gt;
| [[タンパク質ミスフォールディング]]&lt;br /&gt;
| protein misfolding&lt;br /&gt;
|-&lt;br /&gt;
| [[プロテオスタシス]]&lt;br /&gt;
| proteostasis、protein homeostasis、タンパク質恒常性&lt;br /&gt;
|-&lt;br /&gt;
| [[プリオン様伝播]]&lt;br /&gt;
| prion-like propagation、prion-like spreading、prion-like transmission、seeded propagation&lt;br /&gt;
|-&lt;br /&gt;
| [[ストレス顆粒]]&lt;br /&gt;
| stress granule、stress granules、SG&lt;br /&gt;
|-&lt;br /&gt;
| [[RNA代謝異常と神経変性]]&lt;br /&gt;
| RNA dysmetabolism in neurodegeneration、RNA metabolism dysfunction&lt;br /&gt;
|-&lt;br /&gt;
| [[オートファジー・リソソーム系]]&lt;br /&gt;
| autophagy-lysosome system、autophagy-lysosomal pathway、ALP&lt;br /&gt;
|-&lt;br /&gt;
| [[神経炎症]]&lt;br /&gt;
| neuroinflammation&lt;br /&gt;
|-&lt;br /&gt;
| [[選択的神経細胞脆弱性]]&lt;br /&gt;
| selective neuronal vulnerability、selective vulnerability&lt;br /&gt;
|-&lt;br /&gt;
| [[ミトコンドリア機能障害と神経変性]]&lt;br /&gt;
| mitochondrial dysfunction in neurodegeneration&lt;br /&gt;
|-&lt;br /&gt;
| [[エキサイトトキシシティ]]&lt;br /&gt;
| excitotoxicity、excitotoxic neuronal death&lt;br /&gt;
|-&lt;br /&gt;
| [[フェロトーシス]]&lt;br /&gt;
| ferroptosis&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! rowspan=&amp;quot;4&amp;quot; | バイオマーカー&lt;br /&gt;
| [[ニューロフィラメント軽鎖]]&lt;br /&gt;
| neurofilament light chain、neurofilament light、NfL、NFL、NEFL&lt;br /&gt;
|-&lt;br /&gt;
| [[リン酸化タウ]]&lt;br /&gt;
| phosphorylated tau、phospho-tau、p-tau&lt;br /&gt;
|-&lt;br /&gt;
| [[αシヌクレイン・シード増幅アッセイ]]&lt;br /&gt;
| α-synuclein seed amplification assay、αSyn-SAA、α-synuclein SAA&lt;br /&gt;
|-&lt;br /&gt;
| [[Aβ42/Aβ40比]]&lt;br /&gt;
| amyloid-β 42/40 ratio、Aβ42/Aβ40 ratio&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
</feed>